Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers
暂无分享,去创建一个
J. Shen | F. Meric-Bernstam | Ken Chen | K. Shaw | T. Yap | P. Pilié | Taebeom Kim | Yuefan Huang | Heather Y. Lin | J. Gheeya | Ying Yuan | K. Thein | B. Garmezy | J. Rodón | Xianli Jiang | F. Zeineddine | Wan-Jan Wang | Benjamin Garmezy | Xianli Jiang | Xianli Jiang | Xianli Jiang | Benjamin Garmezy | Fadl A Zeineddine